• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Myt Netherlands Parent B.V. ADR (NY: MYTE )

    3.780 UNCHANGED
    Streaming Delayed Price Updated: 7:00 PM EDT, Aug 26, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 3.780
    Bid (Size) 3.470 (1)
    Ask (Size) 4.490 (1)
    Prev. Close 3.780
    Today's Range 3.780 - 3.780
    52wk Range 2.050 - 6.270
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Mytheresa Announces Fourth Quarter and Full Fiscal Year 2024 Earnings Release and Conference Call
    From MYT Netherlands Parent B.V.
    Via Business Wire
    Why Ovid Therapeutics Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga

    Performance

    YTD
    +16.31%
    +16.31%
    1 Month
    -8.92%
    -8.92%
    3 Month
    -30.77%
    -30.77%
    6 Month
    +33.57%
    +33.57%
    1 Year
    +23.93%
    +23.93%

    More News

    Read More
    Mytheresa to Participate in Upcoming Investor Conferences
    From MYT Netherlands Parent B.V.
    Via Business Wire
    Earnings Scheduled For February 15, 2024
    Via Benzinga
    Earnings Outlook For MYT Netherlands Parent
    Via Benzinga
    A Preview Of MYT Netherlands Parent's Earnings
    Via Benzinga
    Analyst Expectations for MYT Netherlands Parent's Future
    Via Benzinga
    MYTE Stock Earnings: MYT Netherlands Parent Beats EPS, Beats Revenue for Q3 2024
    Via InvestorPlace
    Q3 FY24 Results: Mytheresa Posts +18% Net Sales Growth and a Significantly Improved Adjusted EBITDA Margin Compared to the Previous Year Quarter
    From MYT Netherlands Parent B.V.
    Via Business Wire
    Mytheresa Announces Preliminary Third Quarter Results – Double-Digit Topline Growth Significantly Improved Profitability
    From MYT Netherlands Parent B.V.
    Via Business Wire
    Ermenegildo Zegna Reports FY23 Results, Joins Altice USA, Herbalife And Other Big Stocks Moving Lower On Friday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Q2 FY24 Results: Mytheresa posts positive growth and strong financial results outperforming a consolidating market
    From MYT Netherlands Parent B.V.
    Via Business Wire
    Mytheresa Announces Second Quarter of Fiscal Year 2024 Earnings Release and Conference Call; Participating in Upcoming Investor Conferences
    From MYT Netherlands Parent B.V.
    Via Business Wire
    Q1 FY24 Results: Mytheresa Grows +7% in Net Sales in the First Quarter
    From MYT Netherlands Parent B.V.
    Via Business Wire
    Earnings Scheduled For November 28, 2023
    Via Benzinga
    Why Shapeways Holdings Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    12 Consumer Discretionary Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Why CorMedix Shares Are Trading Higher By Over 19%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    12 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Mytheresa Announces First Quarter of Fiscal Year 2024 Earnings Release and Conference Call
    From MYT Netherlands Parent B.V.
    Via Business Wire
    12 Consumer Discretionary Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet
    Via Benzinga
    Why MYT Netherlands Parent Stock Is Soaring Today
    Via The Motley Fool
    Nasdaq Surges 100 Points; First Wave BioPharma Shares Spike Higher
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Clearmind Medicine Shares Are Trading Lower By 53%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.